Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up.
Int J Cardiol Heart Vasc
; 35: 100821, 2021 Aug.
Article
em En
| MEDLINE
| ID: mdl-34179333
ACEi, Angiotensin-converting enzyme inhibitors; ARBs, Angiotensin II receptor blockers; ARNI, Angiotensin receptor-neprilysin inhibitor; CI, Confidence interval; CRT, Cardiac resynchronization therapy; ESC, European Society of Cardiology; GFR, Glomerular filtration rate; HF, Heart failure; HFrEF, Heart failure with reduced ejection fraction; Heart failure; ICD, Implantable cardioverter-defibrillator; LA, Left atrium; LV, Left ventricular; LVEF, Left ventricular ejection fraction; MR, Mitral regurgitation; NYHA, New York Heart Association; OMT, Optimal medical therapy; OR, Odds ratio; RAAS, Renin-angiotensin-aldosterone system; Reverse remodeling; Sacubitril/valsartan
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article